Direct and indirect regulation of fetal globin transcript by RNA-binding protein IGF2BP1

S Steven Coyne (Boston Children's Hospital, Boston, Massachusetts, United States) G GueHo Hwang (Boston Children's Hospital, United States) T Ting Wu (Children’s Hospital, Zhejiang University School of Medicine) M Mir Hossain D Divya S Vinjamur (Boston Children's Hospital, Boston, Massachusetts, United States) M Marlena Starrs J Jing Zeng F Felicia Andresen (Dept. of Hematology/Oncology, Boston Children's Hospital, United States) A Ashley Elizabeth Gutierrez (Boston Children's Hospital, Boston, Massachusetts, United States) A Akiko Shimamura (Dana Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, Massachusetts, United States) D Daniel E Bauer (Boston Children's Hospital, Boston, Massachusetts, United States)

Abstract

Despite extensive investigation, the molecular control of developmental hemoglobin expression remains incompletely elucidated. Hemoglobin switching is controlled by transcription factors, miRNAs, and RNA-binding proteins (RBPs) that enforce gene regulatory changes through development. Here we examine the role of the heterochronically silenced N6 methyladenosine (m6A) RNA-binding protein IGF2BP1 that was previously described to regulate HBG1/2 indirectly by suppressing BCL11A expression through an unknown mechanism. We find that IGF2BP1 binds and activates HIC2, itself a BCL11A repressor. Furthermore, we identify that IGF2BP1 plays a BCL11A-independent role by direct binding to HBG1/2 to promote its translation. Stop codon-proximal m6A-modified coding sequences within HBG2 transcripts are necessary and sufficient for direct positive regulation mediated by IGF2BP1. This work deepens the mechanistic understanding of hemoglobin switching and suggests a physical relationship between heterochronic RBPs and globin transcripts.

Article Details

Journal Blood
Volume / Issue Vol. 1, Issue 1
Published June 24, 2026
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (11)

S

Steven Coyne

Boston Children's Hospital, Boston, Massachusetts, United States

G

GueHo Hwang

Boston Children's Hospital, United States

T

Ting Wu

Children’s Hospital, Zhejiang University School of Medicine

M

Mir Hossain

D

Divya S Vinjamur

Boston Children's Hospital, Boston, Massachusetts, United States

M

Marlena Starrs

J

Jing Zeng

F

Felicia Andresen

Dept. of Hematology/Oncology, Boston Children's Hospital, United States

A

Ashley Elizabeth Gutierrez

Boston Children's Hospital, Boston, Massachusetts, United States

A

Akiko Shimamura

Dana Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, Massachusetts, United States

D

Daniel E Bauer

Boston Children's Hospital, Boston, Massachusetts, United States